IFM Investors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $73.4M | Buy |
571,235
+48,656
| +9% | +$5.7M | 0.49% | 34 |
|
|
2026
Q1 | $62.9M | Buy |
522,579
+12,750
| +3% | +$1.47M | 0.52% | 32 |
|
|
2025
Q4 | $53.7M | Buy |
509,829
+455
| +0.1% | +$42.7K | 0.45% | 35 |
|
|
2025
Q3 | $40M | Buy |
509,374
+4,909
| +1% | +$404K | 0.35% | 43 |
|
|
2025
Q2 | $39.9M | Buy |
504,465
+19,380
| +4% | +$1.54M | 0.38% | 42 |
|
|
2025
Q1 | $43.5M | Sell |
485,085
-3,764
| -0.8% | -$351K | 0.47% | 31 |
|
|
2024
Q4 | $48.6M | Sell |
488,849
-42,909
| -8% | -$4.42M | 0.49% | 27 |
|
|
2024
Q3 | $60.4M | Buy |
531,758
+3,586
| +0.7% | +$426K | 0.58% | 24 |
|
|
2024
Q2 | $65.4M | Buy |
528,172
+6,379
| +1% | +$822K | 0.66% | 21 |
|
|
2024
Q1 | $68.9M | Sell |
521,793
-2,076
| -0.4% | -$256K | 0.75% | 20 |
|
|
2023
Q4 | $57.1M | Buy |
523,869
+5,169
| +1% | +$537K | 0.7% | 21 |
|
|
2023
Q3 | $53.4M | Buy |
518,700
+13,511
| +3% | +$1.46M | 0.7% | 21 |
|
|
2023
Q2 | $58.3M | Buy |
505,189
+24,628
| +5% | +$2.8M | 0.76% | 20 |
|
|
2023
Q1 | $51.1M | Buy |
480,561
+14,294
| +3% | +$1.54M | 0.78% | 21 |
|
|
2022
Q4 | $51.7M | Buy |
466,267
+28,701
| +7% | +$2.93M | 0.87% | 21 |
|
|
2022
Q3 | $37.7M | Buy |
437,566
+6,639
| +2% | +$593K | 0.68% | 26 |
|
|
2022
Q2 | $39.3M | Buy |
430,927
+29,136
| +7% | +$2.58M | 0.69% | 24 |
|
|
2022
Q1 | $33M | Buy |
401,791
+67,249
| +20% | +$5.3M | 0.51% | 39 |
|
|
2021
Q4 | $25.6M | Sell |
334,542
-4,169
| -1% | -$332K | 0.47% | 44 |
|
|
2021
Q3 | $25.4M | Buy |
338,711
+359
| +0.1% | +$27.3K | 0.53% | 37 |
|
|
2021
Q2 | $26.3M | Buy |
338,352
+46,558
| +16% | +$3.46M | 0.54% | 35 |
|
|
2021
Q1 | $21.5M | Buy |
291,794
+35,975
| +14% | +$2.65M | 0.57% | 32 |
|
|
2020
Q4 | $20M | Buy |
255,819
+36,631
| +17% | +$2.8M | 0.63% | 26 |
|
|
2020
Q3 | $17.3M | Buy |
219,188
+23,104
| +12% | +$1.81M | 0.73% | 25 |
|
|
2020
Q2 | $14.5M | Sell |
196,084
-77,916
| -28% | -$5.87M | 0.74% | 23 |
|
|
2020
Q1 | $20.1M | Sell |
274,000
-10,142
| -4% | -$797K | 0.9% | 18 |
|
|
2019
Q4 | $24.7M | Sell |
284,142
-7,507
| -3% | -$617K | 0.87% | 21 |
|
|
2019
Q3 | $23.4M | Buy |
291,649
+99,729
| +52% | +$7.99M | 0.87% | 22 |
|
|
2019
Q2 | $15.4M | Buy |
191,920
+15,383
| +9% | +$1.18M | 0.87% | 23 |
|
|
2019
Q1 | $14M | Buy |
176,537
+14,393
| +9% | +$1.08M | 0.9% | 23 |
|
|
2018
Q4 | $11.8M | Buy |
162,144
+13,369
| +9% | +$944K | 0.96% | 21 |
|
|
2018
Q3 | $10.1M | Buy |
148,775
+20,832
| +16% | +$1.33M | 0.76% | 25 |
|
|
2018
Q2 | $7.41M | Buy |
127,943
+38,986
| +44% | +$2.2M | 0.7% | 28 |
|
|
2018
Q1 | $4.62M | Buy |
88,957
+8,728
| +11% | +$471K | 0.67% | 31 |
|
|
2017
Q4 | $4.31M | Sell |
80,229
-228
| -0.3% | -$12.6K | 0.68% | 31 |
|
|
2017
Q3 | $4.92M | Buy |
80,457
+1,649
| +2% | +$100K | 0.83% | 26 |
|
|
2017
Q2 | $4.82M | Buy |
78,808
+20,050
| +34% | +$1.22M | 0.87% | 24 |
|
|
2017
Q1 | $3.56M | Buy |
58,758
+21,826
| +59% | +$1.32M | 0.9% | 21 |
|
|
2016
Q4 | $2.08M | Buy |
+36,932
| New | +$2.16M | 0.98% | 24 |
|
Other funds holding MRK
LMFP
ATO
QP
IFM Investors's MRK Position: Q2 2026 in Review
IFM Investors increased its Merck (MRK) stake by 9.3% in Q2 2026, buying an estimated $5.7M and bringing the position to 571,235 shares worth $73.4M. The position accounts for 0.49% of the portfolio, ranked #34.
IFM Investors first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- IFM Investors held 571,235 shares of Merck worth $73.4M as of Q2 2026.
- IFM Investors bought 48,656 Merck shares in Q2 2026, an estimated $5.7M.
- Merck made up 0.49% of IFM Investors's portfolio in Q2 2026, its #34 holding.
- IFM Investors first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.